Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measurement of Hormonal Concentration in Chylothorax Fluid in Infants With Congenital Chylothorax

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2006 by Sheba Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00267345
First received: December 19, 2005
Last updated: February 28, 2007
Last verified: January 2006
  Purpose
Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this study hormonal concentration will be measured in the chyle as well as hormonal serum level.

Condition
Congenital Chylothorax

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 15
Study Start Date: March 2005
Estimated Study Completion Date: October 2007
Detailed Description:
Late onset Hypothyroidism was found in infant with congenital hypothyroidism. The hypothesis is that infants with congenital hypothyroidism may lose thyroxin and other hormones via the chylothorax fluid causing transient hypothyroidism. In this study hormonal concentration will be measured in the chyle as well as hormonal serum level.
  Eligibility

Ages Eligible for Study:   up to 10 Weeks   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Infants with congenital chylothorax requiring thorax drain

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00267345

Locations
Israel
Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Jacob Kuint, MD Sheba Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00267345     History of Changes
Other Study ID Numbers: SHEBA-05-3927-JK-CTIL 
Study First Received: December 19, 2005
Last Updated: February 28, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Chylothorax
Pleural Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on December 07, 2016